Levetiracetam Sandoz (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal firing and diminishes abnormal excitability, thereby lowering the probability of seizure initiation and spread throughout the central nervous system.

The specific dose of Levetiracetam Sandoz is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage regimens are individualized and should follow the prescriber’s instructions.

Levetiracetam’s pregnancy safety category is listed as unknown. It should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Limited data exist for breastfeeding; clinicians should weigh the benefits against possible exposure to the infant.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older agents such as carbamazepine or valproate, levetiracetam has a distinct mechanism (SV2A binding) and generally fewer drug‑enzyme interactions, which can simplify combination therapy. It is also associated with a different side‑effect profile, often featuring less hepatic toxicity but a higher incidence of behavioral changes.

Levetiracetam Sandoz should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or extreme temperatures.

Levetiracetam Sandoz is taken orally, usually as a tablet or oral solution, with or without food. The exact administration schedule—once, twice, or multiple times daily—depends on the prescriber’s dosing plan and the patient’s clinical response.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, significant psychiatric effects like depression or suicidal thoughts, and rare blood disorders (e.g., neutropenia). Patients should be instructed to seek immediate medical attention if they notice rash, mood changes, or signs of infection.

Levetiracetam is contraindicated in patients with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for individuals with severe renal impairment who cannot be appropriately dose‑adjusted, and for those with a history of serious psychiatric disorders without close monitoring.